20 results
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... in HIV-AIDS Preventing ... itraconazolea 200 mg PO BID ... #Treatment #management ... #opportunistic
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
duration same as for treatment ... Note: Treatment ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
Esophageal Crohn's Disease Management Algorithm

Assess for Active Symptoms and for Stricturing/Fistulizing Disease
Stricturing DX:
 • Bx r/o
Esophageal Crohn's Disease ... Management Algorithm ... Stricturing/Fistulizing Disease ... #Management #Algorithm ... #treatment #IBD
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
CMV Disease: ... CMV end-organ disease ... Valganciclovir 900 mg PO BID ... #Treatment #management ... #opportunistic
Relapsing Acute Severe Ulcerative Colitis - Management Algorithm
Loss of Response:
 • (Re)consult Colorectal Surgery
 • Assess
Ulcerative Colitis - Management ... Adherence • Assess Disease ... Activity: Flex Sig ... #Algorithm #IBD ... #Treatment
Helicobacter Pylori (H. pylori) Infection - Diagnosis and Management - GrepMed Handbook
Presentation: Dyspepsia / Peptic Ulcer
Pylori (H. pylori) Infection ... Diagnosis and Management ... / Peptic Ulcer Disease ... differentiate past infection ... #Treatment #quadruple
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
General Management ... mg) PO (or IV) BID ... IsosporaBelli #IDSA #Prevention ... #Treatment #management ... #opportunistic
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
suspension 400 mg PO BID ... mucosal #IDSA #Prevention ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
Simplex Virus (HSV) Infections ... • Continue treatment ... HerpesSimplex #HSV #IDSA #Prevention ... #Treatment #management ... #opportunistic
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
should prevent the disease ... 500–1000 mg PO BID ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS